← Back to Search

Orthotic Garment for Down Syndrome

N/A
Waitlist Available
Led By Megan B Flores, PT, MPT, PhD
Research Sponsored by University of St. Augustine for Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Not able to maintain upright sitting independently
Diagnosis of DS
Must not have
Medical restrictions that contraindicate movement
A diagnosis unrelated to DS that limits gross motor movement
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed every 4 weeks from randomization until child takes three independent steps, up to 36 months
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if special shorts called Hip Helpers® can help infants with Down syndrome develop motor skills faster. The shorts keep the baby's legs together to improve balance and muscle use. Infants who can't sit independently will wear these shorts to see if they learn to move better and faster.

Who is the study for?
This trial is for infants with Down syndrome, aged three to nine months, who can't sit up on their own yet. It's not suitable for those with other conditions affecting movement, medical issues that limit movement, or a history of hip problems.
What is being tested?
The study tests if wearing Hip Helpers®, an orthotic garment designed as flexible shorts to improve posture and motor skills, helps these infants develop gross motor skills faster when used in a home program supervised by physical therapists.
What are the potential side effects?
Since the intervention involves wearing an orthotic garment and does not include medication or invasive procedures, no direct side effects are expected. However, discomfort or skin irritation could potentially occur from the garment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I cannot sit up by myself without support.
Select...
I have been diagnosed with Down syndrome.
Select...
I am between 3 to 9 months old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a medical condition that prevents me from moving freely.
Select...
I have a condition unrelated to Down syndrome that affects my ability to move.
Select...
I have had a hip displacement or dislocation in the past.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed every 4 weeks from randomization until child takes three independent steps, up to 36 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed every 4 weeks from randomization until child takes three independent steps, up to 36 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Gross Motor Function Measure - 88 (GMFM-88
Secondary study objectives
Incidence of gross motor milestone achievement, by parent report

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention group: Hip Helpers home programExperimental Treatment1 Intervention
Participants in the intervention group will be given a custom pair of Hip Helpers® to use at home. Parents will begin the Hip Helpers® home program upon study entry and stop the program once the child is able to pull to stand independently. The Hip Helpers® home program protocol, which consists of using the orthotic garment twice daily for 30 minutes each time, will be given to the parents and supervised by the physical therapist. The Hip Helpers® should be donned when the child is actively playing, and not used sleep or when child is inactive.
Group II: Control group: No additional home programActive Control1 Intervention
Participants assigned to the control group will continue with their usual care.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for Down Syndrome, particularly those aimed at improving gross motor skills and postural control, often involve physical therapy and the use of orthotic devices. The Hip Helpers® orthotic garment, for instance, promotes a narrow base of support, encouraging the activation of upright postural muscles. This is important for Down Syndrome patients as it aids in the development of gross motor skills, which are usually delayed. By enhancing postural control and muscle activation, these treatments improve mobility, balance, and overall physical function, thereby significantly enhancing the quality of life for individuals with Down Syndrome.
The Influence of the Physiotherapeutic Program on Selected Static and Dynamic Foot Indicators and the Balance of Elderly Women Depending on the Ground Stability.A preliminary study to evaluate postural improvement in subjects with scoliosis: active therapeutic movement version 2 device and home exercises using the Mulligan's mobilization-with-movement concept.Preliminary trial of postural strategy training using a personal transport assistance robot for patients with central nervous system disorder.

Find a Location

Who is running the clinical trial?

University of St. Augustine for Health SciencesLead Sponsor
7 Previous Clinical Trials
431 Total Patients Enrolled
Megan B Flores, PT, MPT, PhDPrincipal InvestigatorUniversity of St. Augustine for Health Sciences

Media Library

Hip Helpers home program Clinical Trial Eligibility Overview. Trial Name: NCT04603352 — N/A
Down Syndrome Research Study Groups: Intervention group: Hip Helpers home program, Control group: No additional home program
Down Syndrome Clinical Trial 2023: Hip Helpers home program Highlights & Side Effects. Trial Name: NCT04603352 — N/A
Hip Helpers home program 2023 Treatment Timeline for Medical Study. Trial Name: NCT04603352 — N/A
~0 spots leftby Dec 2024